Hepion Pharmaceuticals Inc. buy melinda
Start price
26.04.17
/
50%
€8,950.7
Target price
26.10.17
€14,143
Performance (%)
-37.61%
End price
26.10.17
€5,584.6
Summary
This prediction ended on 26.10.17 with a price of €5,584.6. The BUY prediction by melinda for Hepion Pharmaceuticals Inc. performed very badly with a performance of -37.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hepion Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
| iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
| iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
| iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by melinda for this prediction
In the thread Hepion Pharmaceuticals Inc. diskutieren
Biotechnologie und medizinische Forschung
ContraVir Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen , Entwicklung Placement qui est konzentriert sich hauptsächlich auf die Entwicklung von Medikamenten Herpes - Zoster - Goldunternehmen zu behandeln shingles.The Zeit eine Verbindung Entwicklung genannt Expired FV-100 zur Behandlung von shingles.It est aussi CMX157 Entwicklung
(Laufzeit überschritten)
Stopped prediction by melinda for Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€27.40
25.11.20
25.11.20
€40.00
25.11.21
25.11.21
-16.20%
26.11.21
26.11.21
Hepion Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.00
23.03.20
23.03.20
€100.00
04.11.21
04.11.21
-37.73%
25.11.20
25.11.20
Hepion Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€872.59
31.08.18
31.08.18
€1,767.9
23.01.19
23.01.19
-51.85%
23.01.19
23.01.19
Hepion Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10,405
10.07.16
10.07.16
€12,123
17.08.16
17.08.16
17.09%
17.08.16
17.08.16